Last updated: August 2, 2021
Sponsor: University Hospital, Basel, Switzerland
Overall Status: Active - Recruiting
Phase
N/A
Condition
Mitral Valve Regurgitation
Treatment
N/AClinical Study ID
NCT04418960
2018-02240; ch20Grapow
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- identified Barlow disease suffering from significant mitral insufficiency withindication to surgery
Exclusion
Exclusion Criteria:
- Active endocarditis or any other etiology of mitral insufficiency else than Barlowdisease
- Inability to perform a cardiac MRI (e.g., metallic implants, claustrophobia)
- Pregnancy
- Inability to give consent
Study Design
Total Participants: 10
Study Start date:
September 21, 2018
Estimated Completion Date:
April 30, 2022
Connect with a study center
Cardiac Surgery, University Hospital Basel
Basel, 4031
SwitzerlandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.